Walsh Judith, Potter Michael, Ozer Elizabeth, Gildengorin Ginny, Dass Natasha, Green Lawrence
Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
Department of Family and Community Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
Prev Med Rep. 2021 Jun 10;23:101443. doi: 10.1016/j.pmedr.2021.101443. eCollection 2021 Sep.
Although many trials of cancer screening interventions evaluate efficacy and effectiveness, less research focuses on how to sustain interventions in non-research settings, which limit the potential reach of these interventions. Identifying the factors that influence the potential for sustainability is critical. We evaluate the factors influencing sustainability of PreView, a Cancer Screening Intervention, within the context of the Practical, Robust Implementation and Sustainability Model (PRISM). PRISM includes organizational and patient perspectives of the intervention as well as characteristics of the organizational and patient recipients. It considers how the program or intervention design, external environment, implementation, and sustainability infrastructure and the recipients influence program adoption, implementation, and maintenance. We evaluate the attempts at sustainability of PreView within the constructs of PRISM. Encouraging patients to use PreView was more difficult outside of a clinical trial. Organizational perspectives on how the intervention fit in with other goals, patient perspectives on how the intervention is individualized (i.e. being able to choose which cancer screening to address) and focused on barriers, patient characteristics (i.e. having multiple comorbidities making cancer screening less of a priority), organizational characteristics (i.e. middle managers having competing responsibilities), external environment influences (i.e. reimbursement for achieving certain cancer screening goals), and sustainability infrastructure all affect the likelihood of PreView being sustained in clinical practice. Despite advance planning for sustainability, adapting interventions to achieve sustainability is difficult. Lessons learned from evaluating PreView within the PRISM model can inform future sustainability efforts.
尽管许多癌症筛查干预试验评估了疗效和有效性,但较少有研究关注如何在非研究环境中维持这些干预措施,这限制了这些干预措施的潜在覆盖范围。确定影响可持续性潜力的因素至关重要。我们在实用、稳健实施与可持续性模型(PRISM)的背景下,评估影响癌症筛查干预措施PreView可持续性的因素。PRISM包括干预措施的组织和患者视角,以及组织和患者接受者的特征。它考虑了项目或干预措施的设计、外部环境、实施、可持续性基础设施以及接受者如何影响项目的采用、实施和维持。我们在PRISM的框架内评估PreView的可持续性尝试。在临床试验之外,鼓励患者使用PreView更加困难。关于干预措施如何与其他目标相契合的组织视角、关于干预措施如何个性化(即能够选择进行哪种癌症筛查)以及关注障碍的患者视角、患者特征(即患有多种合并症使癌症筛查不那么优先)、组织特征(即中层管理人员有相互竞争的职责)、外部环境影响(即实现某些癌症筛查目标的报销情况)以及可持续性基础设施,都会影响PreView在临床实践中得以维持的可能性。尽管对可持续性进行了预先规划,但要使干预措施适应以实现可持续性却很困难。从在PRISM模型中评估PreView所吸取的经验教训可为未来的可持续性努力提供参考。